Scientific work

Doç. Dr. İzzet Doğan

107 publications. The source of the information is stated next to each publication.

Back to profile

  1. Comparison of First-Line Pembrolizumab Monotherapy Versus Chemo-Immunotherapy in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Multicenter Real-World Study from Turkey

    Medicina, 2026

    DOI 10.3390/medicina62112136 Open-access full textSource: OpenAlex

  2. Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases

    Cancers, 2026

    DOI 10.3390/cancers18111760 PMID 42279343 Open-access full textSource: OpenAlex

  3. Comparison of prognoses in pancreatic cancer patients receiving neoadjuvant therapy versus adjuvant therapy.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e16451 Open-access full textSource: OpenAlex

  4. Clinicopathological Characteristics and Survival Outcomes of Male Breast Lymphoma

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15187136 PMID 42795909 Open-access full textSource: OpenAlex

  5. The effect of perioperative radiotherapy on prognosis in patients with operable rectal cancer who received neoadjuvant chemotherapy and underwent surgery.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e15681 Source: OpenAlex

  6. Abstract PS4-08-16: Evaluation of Clinicopathological Features and Prognoses of Male Patients with Breast Lymphoma

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-08-16 Source: OpenAlex

  7. Evaluation of clinicopathological features and prognoses of patients with vulvar sarcoma

    International Journal of Gynecological Cancer, 2026

    DOI 10.1016/j.ijgc.2025.104273 Source: OpenAlex

  8. Abstract PS1-09-11: Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps1-09-11 Source: OpenAlex

  9. Abstract PS1-09-10: Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients with Isolated Bone Metastases

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps1-09-10 Source: OpenAlex

  10. Evaluation of clinicopathological features and prognoses of patients with endometrial lymphoma

    International Journal of Gynecological Cancer, 2026

    DOI 10.1016/j.ijgc.2025.103164 Source: OpenAlex

  11. Abstract PS4-08-17: Evaluation of Clinicopathological Features and Prognoses of Female Breast Sarcoma Patients

    Clinical Cancer Research, 2026

    DOI 10.1158/1557-3265.sabcs25-ps4-08-17 Source: OpenAlex

  12. Evaluation of prognoses in patients with de novo metastatic small cell cervical cancer

    International Journal of Gynecological Cancer, 2026

    DOI 10.1016/j.ijgc.2025.102985 Source: OpenAlex

  13. Comparison of clinicopathological features and prognoses of de-novo metastatic male and female bladder cancer patients.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.7_suppl.867 Source: OpenAlex

  14. Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

    JCO Global Oncology, 2026

    DOI 10.1200/go-25-00234 PMID 41855443 Open-access full textSource: OpenAlex

  15. Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103979 PMID 42194940 Open-access full textSource: OpenAlex

  16. Evaluation of clinicopathological features and prognosis of patients with small cell carcinoma of gastrointestinal system origin.

    Journal of Clinical Oncology, 2026

    DOI 10.1200/jco.2026.44.16_suppl.e16481 Source: OpenAlex

  17. Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study

    Molecular and Clinical Oncology, 2025

    DOI 10.3892/mco.2025.2846 PMID 40297501 Open-access full textSource: OpenAlex

  18. The efficacy of second-line chemotherapy in the management of classic and iatrogenic Kaposi sarcoma: An analysis of real-world data

    Medicine, 2025

    DOI 10.1097/md.0000000000041404 PMID 39928795 Open-access full textSource: OpenAlex

  19. Rechallenge of trastuzumab-based therapy in HER2-positive breast cancer patients who progressed after lapatinib plus capecitabine

    Medicine, 2025

    DOI 10.1097/md.0000000000041468 PMID 39928785 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  20. Evaluation of Changes in Clinicopathological Features and Prognosis in Patients with Thyroid Cancer

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14051482 PMID 40094945 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  21. Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-56046-w PMID 38461209 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  22. Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

    Pathology - Research and Practice, 2024

    DOI 10.1016/j.prp.2024.155094 PMID 38219497 5 citations (Europe PMC) Source: OpenAlex

  23. Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey

    Journal of Cancer Research and Therapeutics, 2024

    DOI 10.4103/jcrt.jcrt_392_23 PMID 38261430 5 citations (Europe PMC) Source: OpenAlex

  24. Efficacy of Lapatinib Plus Capecitabine After TDM-1 in HER2-Positive Metastatic Breast Cancer Patients

    Indian Journal of Surgical Oncology, 2024

    DOI 10.1007/s13193-024-01936-8 PMID 39239446 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  25. The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2024

    DOI 10.55730/1300-0144.5784 PMID 38812646 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  26. Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?

    Journal of Cancer Research and Therapeutics, 2024

    DOI 10.4103/jcrt.jcrt_469_23 PMID 38261434 1 citation (Europe PMC) Source: OpenAlex

  27. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

    Medicine, 2024

    DOI 10.1097/md.0000000000037259 PMID 38428877 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  28. Rechallenge of Trastuzumab-based Therapy in HER2-Positive Breast Cancer Patients who Progressed Under TDM-1

    Indian Journal of Surgical Oncology, 2024

    DOI 10.1007/s13193-024-01935-9 PMID 39239424 Open-access full textSource: OpenAlex

  29. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000036750 PMID 38181291 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  30. Clinical factors predicting objective response to bevacizumab-based chemotherapies in advanced and recurrent epithelial ovarian cancer

    Minerva Obstetrics and Gynecology, 2024

    DOI 10.23736/s2724-606x.24.05540-4 PMID 38837188 Source: OpenAlex

  31. Efficacy of inthratecal therapy in breast cancer patients with Leptomeningeal Metastasis

    Eastern Journal Of Medicine, 2024

    DOI 10.5505/ejm.2024.42890 Open-access full textSource: OpenAlex

  32. Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group

    Cancers, 2023

    DOI 10.3390/cancers15061667 PMID 36980554 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  33. Abstract P3-02-06: Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group

    Cancer Research, 2023

    DOI 10.1158/1538-7445.sabcs22-p3-02-06 Source: OpenAlex

  34. Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study

    Medicine, 2023

    DOI 10.1097/md.0000000000032866 PMID 36749246 17 citations (Europe PMC) Open-access full textSource: OpenAlex

  35. Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression

    Scientific Reports, 2023

    DOI 10.1038/s41598-023-35715-2 PMID 37258548 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  36. Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_972_22 PMID 38384023 6 citations (Europe PMC) Source: OpenAlex

  37. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_672_22 PMID 37006064 5 citations (Europe PMC) Source: OpenAlex

  38. Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

    European Journal of Breast Health, 2023

    DOI 10.4274/ejbh.galenos.2023.2022-12-4 PMID 37025570 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  39. Immune checkpoint inhibitors: Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1898_22 PMID 38554314 6 citations (Europe PMC) Source: OpenAlex

  40. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

    Journal of Cancer Research and Clinical Oncology, 2023

    DOI 10.1007/s00432-023-05276-y PMID 37594533 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  41. Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center

    Medicine, 2023

    DOI 10.1097/md.0000000000035383 PMID 37773844 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  42. Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_877_22 PMID 38376301 4 citations (Europe PMC) Source: OpenAlex

  43. Outcomes of the patients with metastatic male breast cancer

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1829_22 PMID 38554305 3 citations (Europe PMC) Source: OpenAlex

  44. Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1827_22 PMID 38554304 1 citation (Europe PMC) Source: OpenAlex

  45. Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1520_22 PMID 38384050 1 citation (Europe PMC) Source: OpenAlex

  46. Efficacy and safety of sorafenib in adult metastatic osteosarcoma patients

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_2581_22 PMID 39023606 Open-access full textSource: OpenAlex

  47. Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process

    Oncology, 2023

    DOI 10.1159/000529030 PMID 36809751 3 citations (Europe PMC) Source: OpenAlex

  48. Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_243_22 PMID 38376293 1 citation (Europe PMC) Source: OpenAlex

  49. Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer.

    Journal of Clinical Oncology, 2023

    DOI 10.1200/jco.2023.41.16_suppl.e17537 Source: OpenAlex

  50. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_1104_21 PMID 36510987 6 citations (Europe PMC) Open-access full textSource: OpenAlex